Over the last 5 years, more than 4000 FDA-regulated clinical trials were initiated worldwide for rare disease treatments.
Chris Adams, PhD, MBA
Advertisement
Articles by Chris Adams, PhD, MBA
Advertisement
Latest Updated Articles
The Journey of Commitment to Ultra-Rare Disease Patients: A Supportive Business ModelPublished: August 5th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Interim Phase 2 IOV-LUNG-202 Data Show Lifileucel’s Potential Treating Advanced NSCLC
5
